Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-32
Closed -$2.94K 2287
2024
Q2
$2.94K Hold
32
﹤0.01% 2084
2024
Q1
$2.95K Hold
32
﹤0.01% 2053
2023
Q4
$3.04K Hold
32
﹤0.01% 2056
2023
Q3
$2.99K Hold
32
﹤0.01% 2042
2023
Q2
$2.93K Hold
32
﹤0.01% 2035
2023
Q1
$2.35K Hold
32
﹤0.01% 2049
2022
Q4
$3K Hold
32
﹤0.01% 1912
2022
Q3
$3K Hold
32
﹤0.01% 1785
2022
Q2
$3K Buy
+32
New +$4.09K ﹤0.01% 1851

Other funds holding AMED

Private Trust Company's AMED Position: Q3 2024 in Review

Private Trust Company sold out of Amedisys (AMED) in Q3 2024, closing a stake of 32 shares — an estimated $2.94K sold.

Private Trust Company first reported a position in AMED in Q2 2022 and held it in 9 quarters. The position peaked at $3.04K in Q4 2023. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Private Trust Company reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Private Trust Company sold 32 Amedisys shares in Q3 2024, an estimated $2.94K.
  • Private Trust Company first reported a position in Amedisys in Q2 2022 and held it in 9 quarters.
  • Private Trust Company's Amedisys position peaked at $3.04K in Q4 2023.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Private Trust Company's 13F filing for Q3 2024, filed 13 Nov 2024.